材料ETF(159944)
Search documents
材料ETF(159944)开盘涨1.43%,重仓股紫金矿业涨2.15%,洛阳钼业涨1.71%
Xin Lang Cai Jing· 2026-03-02 01:36
声明:市场有风险,投资需谨慎。本文基于第三方数据库自动发布,不代表新浪财经观点,任何在本文 出现的信息均只作为参考,不构成个人投资建议。如有出入请以实际公告为准。如有疑问,请联系 biz@staff.sina.com.cn。 3月2日,材料ETF(159944)开盘涨1.43%,报1.846元。材料ETF(159944)重仓股方面,紫金矿业开 盘涨2.15%,洛阳钼业涨1.71%,万华化学涨0.11%,北方稀土涨1.86%,华友钴业跌0.01%,中国铝业涨 1.17%,盐湖股份涨1.05%,赣锋锂业跌0.51%,山东黄金涨3.57%,云铝股份涨1.60%。 材料ETF(159944)业绩比较基准为中证全指原材料指数,管理人为广发基金管理有限公司,基金经理 为姚曦,成立(2015-06-25)以来回报为82.05%,近一个月回报为3.93%。 来源:新浪基金∞工作室 ...
基建、周期全线爆发 全市场百余只ETF单日涨超2%
Zhong Zheng Wang· 2025-07-22 10:55
Group 1 - The A-share market continues its strong momentum, with the Shanghai Composite Index achieving a five-day winning streak and reaching a new high for the year, with a total trading volume of 1.93 trillion yuan, an increase of 200 billion yuan compared to the previous trading day [1] - A total of 902 ETFs in the market rose, accounting for 73.5% of the total, with significant performance in sectors such as old infrastructure, state-owned enterprises, and energy resources [1] - Notably, 106 ETFs saw a daily increase of over 2%, with the leading product, the Infrastructure 50 ETF (516970), surging by 5.56% and achieving a trading volume exceeding 1.1 billion yuan [1] Group 2 - The Engineering Machinery ETF (560280) followed closely with a daily increase of 4.9%, focusing on the demand for machinery equipment in the Yajiang project, and recorded a net purchase of 20 million shares in the previous trading day [1] - The Energy ETF from GF (159945) also benefited from the strong performance of the coal and electricity sectors, rising over 4.5% [1] - Other ETFs, including the Materials ETF (159944), Rare Metals ETF (159608), and Central Enterprise Innovation ETF (515600), also saw daily increases exceeding 2%, showcasing GF Fund's diversified and meticulous layout in the index business [2] Group 3 - The Hong Kong Innovation Drug ETF (513120) maintained high activity, with a daily trading volume surpassing 10.8 billion yuan, and its latest scale exceeding 14.5 billion yuan, leading the market in the pharmaceutical ETF category [2] - The net value of the Hong Kong Innovation Drug ETF has increased by 118.18% over the past year [2]